Shopping Cart
Remove All
Your shopping cart is currently empty
Cofetuzumab
Copy Product Info
😃Good
Catalog No. T82696Cas No. 1869928-62-0
Alias PF-06523435, PF06523435, hu24
Cofetuzumab (PF-06523435) is a monoclonal antibody targeting protein tyrosine kinase 7 (PTK7). It can be used to synthesize the ADC compound cofetuzumab pelidotin.
Cofetuzumab
Cofetuzumab
Copy Product Info😃Good
Catalog No. T82696Alias PF-06523435, PF06523435, hu24Cas No. 1869928-62-0
Cofetuzumab (PF-06523435) is a monoclonal antibody targeting protein tyrosine kinase 7 (PTK7). It can be used to synthesize the ADC compound cofetuzumab pelidotin.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $228 | - | In Stock | |
| 5 mg | $745 | - | In Stock | |
| 10 mg | $1,180 | - | In Stock | |
| 25 mg | $1,870 | - | In Stock | |
| 50 mg | $2,520 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:96.42% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Cofetuzumab (PF-06523435) is a monoclonal antibody targeting protein tyrosine kinase 7 (PTK7). It can be used to synthesize the ADC compound cofetuzumab pelidotin. |
| In vitro | Cofetuzumab (PF-06523435) is a humanized IGG1-κmonoclonal antibody targeting PTK7. |
| Synonyms | PF-06523435, PF06523435, hu24 |
| Reactivity | Human |
| Verified Activity | Immobilized Human PTK7/CCK4 Protein (Fc) at 2 μg/mL (30 μL/well) can bind Cofetuzumab. The EC50 is 0.08093 μg/mL.  |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | PTK7/CCK4 |
| Molecular Weight | 146.7 kDa |
| Cas No. | 1869928-62-0 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Cofetuzumab | purchase Cofetuzumab | Cofetuzumab cost | order Cofetuzumab | Cofetuzumab in vitro | Cofetuzumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.